GLP-1 T (30mg) *U.S. SOURCED*

Tirzepatide is a dual agonist targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, studied for its combined effects on glucose control and metabolic regulation. This dual-receptor activity may enhance insulin sensitivity, reduce appetite, and improve energy utilization in preclinical settings. Researchers examine its potential to influence body composition, lipid metabolism, and hormonal signaling beyond what is seen with single-receptor agents. Studies also investigate how tirzepatide’s mechanisms affect weight regulation and metabolic resilience over time. For research use only. Not approved for human consumption.